Rabbit Recombinant Monoclonal TAU phospho S202 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Rat, Human samples. Cited in 16 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Dot | ICC/IF | Flow Cyt | WB | IHC-P | |
---|---|---|---|---|---|
Human | Expected | Not recommended | Not recommended | Tested | Not recommended |
Mouse | Expected | Not recommended | Not recommended | Tested | Not recommended |
Rat | Expected | Not recommended | Not recommended | Tested | Not recommended |
Synthetic peptide | Tested | Not recommended | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/5000 - 1/10000 | Notes - |
Species Rat | Dilution info 1/5000 - 1/10000 | Notes - |
Species Human | Dilution info 1/5000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide | Dilution info - | Notes - |
Select an associated product type
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
MAPT phospho S202
MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
Rabbit Recombinant Monoclonal TAU phospho S202 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse, Rat, Human samples. Cited in 16 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
The specificity of this antibody refers to P10636-8.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Tau also known as microtubule-associated protein Tau (MAPT) plays an important role in stabilizing microtubules in neuronal cells. Tau is primarily found in the central nervous system but also exists in peripheral neurons. Human Tau protein comes in six isoforms due to alternative splicing with molecular weights ranging from 48 kDa to 67 kDa. This protein predominantly locates in the axons of neurons where it maintains the stability of microtubule tracks necessary for axonal transport.
Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.
Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.
Tau is closely associated with Alzheimer's disease and frontotemporal dementia. In Alzheimer's disease hyperphosphorylated Tau aggregates into paired helical filaments forming neurofibrillary tangles while similar aggregates are observed in frontotemporal dementia. In these conditions Tau links to amyloid precursor protein (APP) where misregulated phosphorylation-driven interactions contribute to neurodegeneration. Identifying phospho-Tau and its altered interactions with related proteins aids in understanding and potentially treating these disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
The molecular weight observed is consistent with what has been described in the literature (PMID: 28382304, 32692785 and 30120733).
Blocking and diluting buffer: 5% NFDM/TBST
All lanes: Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (ab108387) at 1/1000 dilution
Lane 1: Rat hippocampus lysate at 15 µg
Lane 2: Rat hippocampus lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
Lane 3: Rat cerebral cortex lysate at 15 µg
Lane 4: Rat cerebral cortex lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
Lane 5: Mouse hippocampus lysate at 15 µg
Lane 6: Mouse hippocampus lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
All lanes: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 32-72 kDa
The molecular weight observed is consistent with what has been described in the literature (PMID: 28382304, 32692785 and 30120733).
Blocking and diluting buffer: 5% NFDM/TBST
All lanes: Western blot - Anti-Tau (phospho S202) antibody [EPR2402] (ab108387) at 1/1000 dilution
Lane 1: Human brain lysate at 15 µg
Lane 2: Human brain lysate then the membrane treated with Alkaline Phosphatase for 1 hour at 15 µg
All lanes: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 78 kDa
Observed band size: 32-72 kDa
Dot blot analysis using 1/1000 dilution ab108387 and Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) secondary at 1/100000 dilution.
Blocking and diluting buffer: 5% NFDM/TBST
Lane 1: Tau non-phospho peptide
Lane 2: Tau S199 phospho peptide
Lane 3: Tau S202 phospho peptide
Lane 4: Tau S199+S202 phospho peptide
Exposure time: 3 minutes
Image collected and cropped by CiteAb under a CC-BY license from the publication
Tau (phospho S202) western blot using anti-Tau (phospho S202) antibody [EPR2402] ab108387. Publication image and figure legend from Sun, W., Lee, S., et al., 2016, Sci Rep, PubMed 27708431.
ab108387 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab108387 please see the product overview.
MB reduced Tau phosphorylation by endogenous kinases in 293T cells.(a) Representative immunoblot of lysates from 293T cells transfected with 4R2N Tau. Transfected cells were treated with AC, MB and OS for 3 h at concentrations indicated in the panel. The levels of pTau S262, S396, S214, S202 and total Tau were reported with β-actin as the loading control. (b–e) Quantification of the ratio of pTau to total Tau presented as the percent of the level found in cells transfected with Tau but without drug treatment. Results are mean ± SD (n = 3). *0.01 < P < 0.05; **0.001 < P < 0.01 ***P < 0.001. Student’s t test is conducted between corresponding values in AC and OS or MB and OS group.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com